Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
Provided By GlobeNewswire
Last update: May 22, 2025
- Vigil’s shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a non-tradeable contingent value right of $2.00 per share in cash following the first commercial sale of VG-3927 -
Read more at globenewswire.comNASDAQ:VIGL (6/5/2025, 10:17:00 AM)
7.89
-0.01 (-0.13%)
Find more stocks in the Stock Screener
VIGL Latest News and Analysis
9 days ago - ChartmillOn Tuesday, there are stocks with unusual volume. Let's take a look.Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
13 days ago - ChartmillWhich stocks have an unusual volume on Friday?In today's session, these stocks are experiencing unusual volume.
